Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Kyong Joo Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9175-9164; OpenAlex author ID A5044878573. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Effects of Chemotherapy on Survival Outcomes in Older Patients with Metastatic Pancreatic Cancer: A Nationwide Population-Based Study. Last author DOI 10.5009/gnl250551↗
  2. Correction: Park et al. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Cancers 2… Co-author DOI 10.3390/cancers17060963↗
  3. Convolutional neural network model for automatic recognition and classification of pancreatic cancer cell based on analysis of lipid droplet on unlabeled sampl… Co-author DOI 10.1016/j.cmpb.2024.108041↗
  4. Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea. Co-author DOI 10.3390/cancers16183173↗
  5. Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea. Co-author DOI 10.1016/j.ejca.2023.05.020↗
  6. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradi… Co-author DOI 10.5009/gnl17216↗
  7. Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy. Co-author DOI 10.1016/j.radonc.2017.04.010↗
  8. Comparison of cytologic preparation methods in endoscopic ultrasound-guided fine needle aspiration for diagnosis of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.05.006↗
  9. A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer. Co-author DOI 10.5009/gnl15186↗
  10. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Co-author DOI 10.3349/ymj.2013.54.3.643↗
  11. Gastrointestinal hemorrhage after concurrent chemoradiotherapy in locally advanced pancreatic cancer. Co-author DOI 10.5009/gnl.2013.7.1.106↗
  12. Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/j.1349-7006.2012.02358.x↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Byung Kyu Park · 4 shared papers, 2023–2026 · strength 1.21
  2. Kang Ju Son · 4 shared papers, 2023–2026 · strength 1.21
  3. Chan Su Park · 3 shared papers, 2024–2026 · strength 1.00
  4. Moon Jae Chung · 4 shared papers, 2013–2024 · strength 0.33
  5. Jung Kyu Choi · 1 shared paper, 2023 · strength 0.22
  6. Eunae Cho · 1 shared paper, 2024 · strength 0.19
  7. Seok Jin Hong · 1 shared paper, 2024 · strength 0.19
  8. Se Woo Park · 1 shared paper, 2024 · strength 0.19
  9. Jee Suk Chang · 2 shared papers, 2017–2018 · strength 0.19
  10. Seung Yeun Chung · 2 shared papers, 2017–2018 · strength 0.19
  11. Byung Min Lee · 2 shared papers, 2017–2018 · strength 0.19
  12. Jinsil Seong · 2 shared papers, 2017–2018 · strength 0.19
  13. Si Young Song · 4 shared papers, 2012–2016 · strength 0.17
  14. Seung Woo Park · 3 shared papers, 2013–2016 · strength 0.14
  15. Jeong Youp Park · 3 shared papers, 2013–2016 · strength 0.14
  16. Seungmin Bang · 2 shared papers, 2013–2016 · strength 0.10
  17. Jae Woo Kim · 1 shared paper, 2016 · strength 0.08
  18. Jae Bock Chung · 1 shared paper, 2013 · strength 0.04
  19. Hye Won Chung · 1 shared paper, 2012 · strength 0.04
  20. Jong‐Baeck Lim · 1 shared paper, 2012 · strength 0.04
  21. Woo Jung Lee · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.